Trial Profile
A Phase 3, Randomized, Double-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Recombinant Human Thrombin (rhThrombin) and Thrombin-JMI (Bovine Thrombin) in Surgical Hemostasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Thrombin alfa (Primary) ; Thrombin
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors ZymoGenetics
- 28 May 2014 New trial record